van Deventer Sander

CIK 00015430843 companies1411 DC NAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001543084

Recent Transactions

38 trades

Award
HOOKIPA Pharma Inc.$HOOK
Common Stock
2020-10-21+2,485→ 2,485 total
Award
HOOKIPA Pharma Inc.$HOOK
Stock Option (Right to Buy)
2020-06-18+9,600→ 9,600 total
Award
uniQure N.V.$QURE
Ordinary Shares
2020-02-27+12,380→ 61,599 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2020-02-27+21,719→ 21,719 total
Award
uniQure N.V.$QURE
Ordinary Shares
2020-01-31+6,092→ 49,219 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$62.10/sh−923→ 43,127 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$61.27/sh−1,304→ 44,050 total
Award
HOOKIPA Pharma Inc.$HOOK
Stock Option (Right to Buy)
2019-12-18+9,600→ 9,600 total
Award
uniQure N.V.$QURE
Ordinary Shares
2019-09-17+15,000→ 45,354 total
Award
HOOKIPA Pharma Inc.$HOOK
Stock Option (Right to Buy)
2019-04-17+19,200→ 19,200 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2019-01-28$31.31/sh−1,358→ 40,313 total
Award
uniQure N.V.$QURE
Ordinary Shares
2019-01-25+10,913→ 41,571 total
Award
uniQure N.V.$QURE
Ordinary Shares
2019-01-25+5,589→ 30,658 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2019-01-25+18,325→ 18,325 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2018-01-29$18.53/sh−5,985→ 25,069 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2018-01-26+20,788→ 20,788 total
Award
uniQure N.V.$QURE
Ordinary Shares
2018-01-26+7,795→ 31,054 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2017-09-20+150,000→ 150,000 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2017-01-27+11,000→ 11,000 total
Award
uniQure N.V.$QURE
Restricted Stock Units
2017-01-27+11,000→ 16,000 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2017-01-19+9,500→ 9,500 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-09-30+2,263→ 5,057 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock Warrants (right to buy)
2016-08-02+1,159,090→ 1,159,090 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2016-08-02+1,545,454→ 6,199,961 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-06-30+1,427→ 2,794 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock Warrants (right to buy)
2016-06-29+991,964→ 991,964 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2016-06-29+1,322,618→ 4,654,507 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2016-06-13+5,500→ 5,500 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-03-31+1,367→ 1,367 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2016-03-14+881,745→ 3,331,889 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock Warrants (right to buy)
2016-03-14+661,309→ 661,309 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2015-06-17+5,500→ 5,500 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2014-03-20−11,000→ 11,000 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12$8.00/sh+36,416→ 2,450,144 total
Conversion
ARGOS THERAPEUTICS INC
Series D Preferred Stock
2014-02-12−984,840→ 0 total
Conversion
ARGOS THERAPEUTICS INC
Series E Preferred Stock
2014-02-12−1,428,888→ 0 total
Conversion
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12+984,840→ 984,840 total
Conversion
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12+1,428,888→ 2,413,728 total

Companies

Recent Filings

Address

C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35

1411 DC NAARDEN, P7

View on SEC.gov